The Food and Drug Administration (FDA) awarded a $840,181.30 definitive contract to Brightfield Group LLC, a for-profit organization, for online data subscription and specialized analytic services. The contract, which runs from July 2021 to February 2025, is a firm fixed-price agreement with no set-aside designation. Through this contract, Brightfield Group will provide exploratory behavioral economics studies, data subscriptions, and analytical support to aid the FDA's regulatory and public health decision-making. Additionally, the Centers for Disease Control and Prevention (CDC) in Pittsburgh awarded a $48,800 purchase order to Brightfield Group for data purchasing services from June 2021 to June 2022 to support disease monitoring and public health programs.
Generated 6/13/24, 9:33 AM